CO-TECHSTARS
16.11.2020 14:02:12 CET | Business Wire | Press release
Techstars, the worldwide network that helps entrepreneurs succeed, is now accepting entries for the Techstars Sustainability Challenge from anyone with ideas for how to reduce the significant toll global supply chains have on the environment. Winners will be showcased at the first Techstars Sustainability Summit in April, and at least one will have the opportunity to develop a proof-of-concept with a Techstars Sustainability Challenge Program Partner. Techstars Pathfinder members and Challenge Partners for this effort are: ABN AMRO, Cargill, Comcast NBCUNIVERSAL LIFT LABS, EG, Endeavor, Equinor, Princeton University through Princeton Innovation and the Andlinger Center for Energy and the Environment, Semapa NEXT investment company, Stanley Black & Decker, The Heritage Group, The Nature Conservancy, Temasek and World Federation of United Nations Associations (WFUNA).
The Techstars Sustainability Challenge is designed to accelerate efforts to develop new products, solutions and processes that will improve supply chain operations. Techstars and its Challenge Partners see collaborative efforts like this as critical to reducing the negative environmental impacts of supply chains and creating efficiencies that will drive long-term positive impacts for industries, markets and people around the world.
“A massive challenge in sustainability today is improving operations of the global economy’s complex supply chains to be more efficient and environmentally friendly. It’s difficult for companies to get insights into their overall footprint and the operations of their suppliers, and ultimately alter behaviors and systems,” says Cody Simms, SVP of Investments and leader of Techstars’ global sustainability programs. “Through the Techstars Sustainability Challenge, we are putting out the call to entrepreneurs, tech startups, researchers, NGOs and corporate innovators to help us find and scale solutions to one of the world’s most urgent sustainability problems. We are looking for innovators who can help build a more sustainable supply chain through their work on the measurement and management of supply chain impacts.”
Entry Categories
Innovators will submit their entries to one of two specific areas:
- Data & Automation: Solutions to help companies use automation, internal data collection, or more accurate inferences of external data sources to better measure, trace, and track the impact of their supply chain footprints.
- Materials & End-of-life Impact: Enable a manufacturer to reduce the impact of a product’s footprint through new materials innovations, either natural or synthetic. Solutions can range from limiting the extractive process for obtaining the raw materials, extending product lifespan, or mitigating the product’s end-of-life impact on the environment.
A panel of sustainability experts from Techstars along with Challenge Partners will judge all submissions on three criteria: problem-solution fit; scale of the solution’s potential impact; and the ability to implement a proof-of-concept with an enterprise organization.
Timeline
- November 16, 2020: Applications open
- March 8, 2021: Applications close
- March 25, 2021: Finalists notified
- April 1, 2021: Proof-of-Concept (POC) Working Session (virtual) - Finalists will deliver their pitches to judges, receive formal introductions to relevant corporate business units, and participate in matchmaking workshops with Founding Partners to brainstorm proof-of-concept and pilot concepts.
- April 15, 2021: Techstars Sustainability Summit Event (virtual) - Winners announced. At least one winner will have the opportunity to run a proof-of-concept with one of our Challenge Partners.
“The goal is actionable impact,” adds Simms. “The winners’ journey with Techstars won’t end in a competitive victory. We will partner them with mentors from our global participating partner network so they can immediately begin working on building out real-world solutions that will affect meaningful change.”
Building a Strong Network of Mentors and Investors
Techstars Pathfinder Membership matches corporate innovators with exactly the right startups who can turn innovative ideas into business opportunities and open new revenue streams. The ultimate goal is to speed corporate innovators to action. That can mean establishing partnerships, building proofs of concept, identifying and seizing investment opportunities, or acquiring teams, technologies and/or customers.
The Techstars Sustainability Challenge is the anchor project for bringing together a group of members in 2020 to drive real progress toward a more sustainable world.
Follow this link to enter the Techstars Sustainability Challenge. Click here to learn more about partnership opportunities.
About Techstars
The Techstars worldwide network helps entrepreneurs succeed. Founded in 2006, Techstars began with three simple ideas — entrepreneurs create a better future for everyone, collaboration drives innovation, and great ideas can come from anywhere. Now we are on a mission to enable every person on the planet to contribute to, and benefit from, the success of entrepreneurs. In addition to operating accelerator programs and venture capital funds, we do this by connecting startups, investors, corporations, and cities to help build thriving startup communities. Techstars has invested in more than 2,200 companies that today have a combined market cap valuation of more than $30 Billion. www.techstars.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005191/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
